PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NEFRX vs. WCPNX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between NEFRX and WCPNX is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.9

Performance

NEFRX vs. WCPNX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Loomis Sayles Core Plus Bond Fund (NEFRX) and Weitz Core Plus Income Fund (WCPNX). The values are adjusted to include any dividend payments, if applicable.

-2.00%-1.00%0.00%1.00%2.00%3.00%4.00%AugustSeptemberOctoberNovemberDecember2025
0.17%
1.38%
NEFRX
WCPNX

Key characteristics

Sharpe Ratio

NEFRX:

0.41

WCPNX:

1.25

Sortino Ratio

NEFRX:

0.61

WCPNX:

1.87

Omega Ratio

NEFRX:

1.07

WCPNX:

1.23

Calmar Ratio

NEFRX:

0.17

WCPNX:

1.64

Martin Ratio

NEFRX:

0.99

WCPNX:

3.93

Ulcer Index

NEFRX:

2.40%

WCPNX:

1.66%

Daily Std Dev

NEFRX:

5.77%

WCPNX:

5.25%

Max Drawdown

NEFRX:

-20.25%

WCPNX:

-13.87%

Current Drawdown

NEFRX:

-9.98%

WCPNX:

-2.56%

Returns By Period

In the year-to-date period, NEFRX achieves a 0.71% return, which is significantly higher than WCPNX's 0.31% return. Over the past 10 years, NEFRX has underperformed WCPNX with an annualized return of 1.24%, while WCPNX has yielded a comparatively higher 3.10% annualized return.


NEFRX

YTD

0.71%

1M

0.98%

6M

0.17%

1Y

2.03%

5Y*

-0.60%

10Y*

1.24%

WCPNX

YTD

0.31%

1M

0.95%

6M

1.37%

1Y

6.20%

5Y*

2.88%

10Y*

3.10%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


NEFRX vs. WCPNX - Expense Ratio Comparison

NEFRX has a 0.71% expense ratio, which is lower than WCPNX's 0.89% expense ratio.


WCPNX
Weitz Core Plus Income Fund
Expense ratio chart for WCPNX: current value at 0.89% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.89%
Expense ratio chart for NEFRX: current value at 0.71% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.71%

Risk-Adjusted Performance

NEFRX vs. WCPNX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEFRX
The Risk-Adjusted Performance Rank of NEFRX is 1313
Overall Rank
The Sharpe Ratio Rank of NEFRX is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of NEFRX is 1515
Sortino Ratio Rank
The Omega Ratio Rank of NEFRX is 1212
Omega Ratio Rank
The Calmar Ratio Rank of NEFRX is 1212
Calmar Ratio Rank
The Martin Ratio Rank of NEFRX is 1313
Martin Ratio Rank

WCPNX
The Risk-Adjusted Performance Rank of WCPNX is 6565
Overall Rank
The Sharpe Ratio Rank of WCPNX is 6363
Sharpe Ratio Rank
The Sortino Ratio Rank of WCPNX is 6868
Sortino Ratio Rank
The Omega Ratio Rank of WCPNX is 6161
Omega Ratio Rank
The Calmar Ratio Rank of WCPNX is 7979
Calmar Ratio Rank
The Martin Ratio Rank of WCPNX is 5252
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NEFRX vs. WCPNX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Core Plus Bond Fund (NEFRX) and Weitz Core Plus Income Fund (WCPNX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NEFRX, currently valued at 0.41, compared to the broader market-1.000.001.002.003.004.000.411.25
The chart of Sortino ratio for NEFRX, currently valued at 0.61, compared to the broader market0.005.0010.000.611.87
The chart of Omega ratio for NEFRX, currently valued at 1.07, compared to the broader market1.002.003.004.001.071.23
The chart of Calmar ratio for NEFRX, currently valued at 0.17, compared to the broader market0.005.0010.0015.0020.000.171.64
The chart of Martin ratio for NEFRX, currently valued at 0.99, compared to the broader market0.0020.0040.0060.0080.000.993.93
NEFRX
WCPNX

The current NEFRX Sharpe Ratio is 0.41, which is lower than the WCPNX Sharpe Ratio of 1.25. The chart below compares the historical Sharpe Ratios of NEFRX and WCPNX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00AugustSeptemberOctoberNovemberDecember2025
0.41
1.25
NEFRX
WCPNX

Dividends

NEFRX vs. WCPNX - Dividend Comparison

NEFRX's dividend yield for the trailing twelve months is around 3.89%, less than WCPNX's 6.98% yield.


TTM20242023202220212020201920182017201620152014
NEFRX
Loomis Sayles Core Plus Bond Fund
3.89%3.92%3.59%3.09%2.14%2.04%2.52%2.88%2.68%3.18%2.59%3.26%
WCPNX
Weitz Core Plus Income Fund
6.98%7.45%9.41%2.93%2.23%3.31%2.72%2.55%2.11%2.43%1.78%0.58%

Drawdowns

NEFRX vs. WCPNX - Drawdown Comparison

The maximum NEFRX drawdown since its inception was -20.25%, which is greater than WCPNX's maximum drawdown of -13.87%. Use the drawdown chart below to compare losses from any high point for NEFRX and WCPNX. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-9.98%
-2.56%
NEFRX
WCPNX

Volatility

NEFRX vs. WCPNX - Volatility Comparison

Loomis Sayles Core Plus Bond Fund (NEFRX) has a higher volatility of 1.47% compared to Weitz Core Plus Income Fund (WCPNX) at 1.35%. This indicates that NEFRX's price experiences larger fluctuations and is considered to be riskier than WCPNX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


1.00%1.20%1.40%1.60%1.80%AugustSeptemberOctoberNovemberDecember2025
1.47%
1.35%
NEFRX
WCPNX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab